Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport

Abstract

Tumor necrosis factor (TNF) is a critical host resistance factor against tuberculosis. However, excess TNF produces susceptibility by increasing mitochondrial reactive oxygen species (mROS), which initiate a signaling cascade to cause pathogenic necrosis of mycobacterium-infected macrophages. In zebrafish, we identified the mechanism of TNF-induced mROS in tuberculosis. Excess TNF in mycobacterium-infected macrophages elevates mROS production by reverse electron transport (RET) through complex I. TNF-activated cellular glutamine uptake leads to an increased concentration of succinate, a Krebs cycle intermediate. Oxidation of this elevated succinate by complex II drives RET, thereby generating the mROS superoxide at complex I. The complex I inhibitor metformin, a widely used antidiabetic drug, prevents TNF-induced mROS and necrosis of Mycobacterium tuberculosis –infected zebrafish and human macrophages; metformin may therefore be useful in tuberculosis therapy.

References 64

1. 1.

   Keane J, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345, 1098–1104 (2001 ).

   Not in our library10.1056/nejmoa011110

2. 2.
   Is Mycobacterium tuberculosis infection life long? · 2019

   No notice
3. 3.

   Whitworth LJ, Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. PNAS 118(10):e2024852118. doi: (2021 ).

   Not in our library10.1073/pnas.2024852118

4. 4.

   Tobin DM, Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434–446 (2012 ).

   Not in our library10.1016/j.cell.2011.12.023

5. 5.

   Roca FJ, Ramakrishnan L, TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153, 521–534 (2013 ).

   Not in our library10.1016/j.cell.2013.03.022

6. 6.
   TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit · 2019

   No notice
7. 7.

   Cambier CJ, Falkow S, Ramakrishnan L, Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell 159, 1497–1509 (2014 ).

   Not in our library10.1016/j.cell.2014.11.024

8. 8.

   Clay H, Volkman HE, Ramakrishnan L, Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29, 283–294 (2008 ).

   Not in our library10.1016/j.immuni.2008.06.011

9. 9.

   Tobin DM, The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717–730 (2010 ).

   Not in our library10.1016/j.cell.2010.02.013

10. 10.

    Whitworth L, A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis. Elife 10:e61722. doi: (2021 ).

    Not in our library10.7554/elife.61722

11. 11.

    Marakalala MJ, Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nat Med 22, 531–538 (2016 ).

    Not in our library10.1038/nm.4073

12. 12.

    Murphy MP, How mitochondria produce reactive oxygen species. Biochem J 417, 1–13 (2009 ).

    Not in our library10.1042/bj20081386

13. 13.
    Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease · 2017

    No notice
14. 14.

    Fato R, Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species. Biochim Biophys Acta 1787, 384–392 (2009 ).

    Not in our library10.1016/j.bbabio.2008.11.003

15. 15.
    Control of mitochondrial superoxide production by reverse electron transport at complex I · 2018

    Corrected
16. 16.

    Nuskova H, Vrbacky M, Drahota Z, Houstek J, Cyanide inhibition and pyruvate-induced recovery of cytochrome c oxidase. J Bioenerg Biomembr 42, 395–403 (2010 ).

    Not in our library10.1007/s10863-010-9307-6

17. 17.

    Burger N, A sensitive mass spectrometric assay for mitochondrial CoQ pool redox state in vivo. Free Radic Biol Med 147, 37–47 (2020 ).

    Not in our library10.1016/j.freeradbiomed.2019.11.028

18. 18.

    Chouchani ET, Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435 (2014 ).

    Not in our library10.1038/nature13909

19. 19.

    Mills EL, Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. Cell 167, 457–470 e413 (2016 ).

    Not in our library10.1016/j.cell.2016.08.064

20. 20.

    Zhang DW, RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009 ).

    Not in our library10.1126/science.1172308

21. 21.

    Goossens V, Stange G, Moens K, Pipeleers D, Grooten J, Regulation of tumor necrosis factor-induced, mitochondria- and reactive oxygen species-dependent cell death by the electron flux through the electron transport chain complex I. Antioxid Redox Signal 1, 285–295 (1999 ).

    Not in our library10.1089/ars.1999.1.3-285

22. 22.

    https://www.proteinatlas.org/

    Not in our library

23. 23.

    Broer A, Rahimi F, Broer S, Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. J Biol Chem 291, 13194–13205 (2016 ).

    Not in our library10.1074/jbc.m115.700534

24. 24.

    https://www.sanger.ac.uk/tool/basicz/

    Not in our library

25. 25.

    Zhong CQ, Quantitative phosphoproteomic analysis of RIP3-dependent protein phosphorylation in the course of TNF-induced necroptosis. Proteomics 14, 713–724 (2014 ).

    Not in our library10.1002/pmic.201300326

26. 26.

    Stepanova A, Shurubor Y, Valsecchi F, Manfredi G, Galkin A, Differential susceptibility of mitochondrial complex II to inhibition by oxaloacetate in brain and heart. Biochim Biophys Acta 1857, 1561–1568 (2016 ).

    Not in our library10.1016/j.bbabio.2016.06.002

27. 27.

    Wang Z, Jiang H, Chen S, Du F, Wang X, The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228–243 (2012 ).

    Not in our library10.1016/j.cell.2011.11.030

28. 28.

    Prag HA, Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo. Cardiovasc Drugs Ther, 1:1–13. doi: (2020 ).

    Not in our library10.1007/s10557-020-07033-6

29. 29.
    Role of Mitochondria in the Mechanism(s) of Action of Metformin · 2019

    No notice
30. 30.

    Stepanova A, Reverse electron transfer results in a loss of flavin from mitochondrial complex I: Potential mechanism for brain ischemia reperfusion injury. J Cereb Blood Flow Metab 37, 3649–3658 (2017 ).

    Not in our library10.1177/0271678x17730242

31. 31.

    Tannahill GM, Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013 ).

    Not in our library10.1038/nature11986

32. 32.

    Łabuzek K, Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 62, 956–965 (2010 ).

    Not in our library10.1016/s1734-1140(10)70357-1

33. 33.

    Singhal A, Metformin as adjunct antituberculosis therapy. Sci Transl Med 6, 263ra159 (2014 ).

    Not in our library10.1126/scitranslmed.3009885

34. 34.

    Tsenova L, Singhal A, Effects of host-directed therapies on the pathology of tuberculosis. J Pathol 250, 636–646 (2020 ).

    Not in our library10.1002/path.5407

35. 35.

    Padmapriyadarsini C, Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial. BMJ Open 9, e024363 (2019 ).

    Not in our library10.1136/bmjopen-2018-024363

36. 36.

    Dutta NK, Pinn ML, Karakousis PC, Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice. Antimicrob Agents Chemother 61, (2017 ).

    Not in our library10.1128/aac.00652-17

37. 37.

    Muthuswamy P, Hu TC, Carasso B, Antonio M, Dandamudi N, Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature. Chest 107, 1621–1630 (1995 ).

    Not in our library10.1378/chest.107.6.1621

38. 38.

    Smego RA, Ahmed N, A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis 7, 208–213 (2003 ).

    Not in our library

39. 39.

    Rotenone as an Insecticide. Nature 132, 167–167 (1933 ).

    Not in our library

40. 40.

    Balba H, Review of strobilurin fungicide chemicals. Journal of Environmental Science and Health, Part B 42, 441–451 (2007 ).

    Not in our library10.1080/03601230701316465

Cited by papers we hold 2

• Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention · 2024
  No notice
• Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.